Guardian Pharmacy Services, Inc.·4

Mar 24, 4:15 PM ET

Forbes Kendall 4

Research Summary

AI-generated summary

Updated

Guardian Pharmacy (GRDN) EVP Forbes Kendall Sells 346,672 Shares

What Happened
Forbes Kendall, Executive Vice President, Sales & Operations of Guardian Pharmacy Services, sold 346,672 shares of the company's Class A common stock on March 20, 2026. The shares were disposed at $29.68 per share for a total transaction value of approximately $10,290,092. The sale was made pursuant to an underwriting agreement involving the issuer, selling stockholders, and underwriters (BofA Securities and Jefferies), i.e., the shares were sold in connection with an offering rather than an open-market purchase.

Key Details

  • Transaction date: March 20, 2026; filing date: March 24, 2026 (Form 4 filed within the normal reporting window).
  • Transaction type/code: Sale (S). Price per share: $29.68. Shares sold: 346,672. Total proceeds: ~$10.29 million.
  • Footnote: F1 — Shares are Class A common stock sold pursuant to the Underwriting Agreement dated March 18, 2026, with BofA Securities, Inc. and Jefferies LLC as representatives of the underwriters.
  • Shares owned after the transaction: not stated in the provided filing excerpt.
  • Remarks: Insider title reported as Executive Vice President, Sales & Operations.

Context
Sales executed under an underwriting agreement typically reflect shares sold as part of a registered offering (secondary sale by selling stockholders) rather than a discretionary open-market sale. Insider sales are routine and do not, by themselves, indicate the insider's view of company fundamentals; retail investors should consider this alongside other filings and company news.